Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2012, Vol. 32 Issue (04): 18-21    DOI:
    
CXCL12 Chemokine Up-regulates Connexins Expression in Mesenchymal Stem Cells Through PI3K/Akt Pathway
CHI Xiao-wei, HOU Jing-bo, MENG Jia, ZHANG Yi-na
The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China
Download: HTML   PDF(591KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Heart cell therapy provides an unconvention connective measure to compensate for myocyte loss in the infacted heart.Nevertheless poor survival of doner cells is one of the major concerns that hampers a better prognosis.Additionally,poor engraftment and lack of functional coupling of donor cells with the viable host tissue greatly impede cell-to-cell signaling and electric conmmunication. Connexins with its dual role as an antiapoptotic and as a gap-junctional protein,can effectively resolve both of these issues. CXCL12,a member of the chemokine CXC subfamily,may play a role in stem cell survival and proliferation.CXCL12 activates several signaling pathways in stem cells,particularly the survival kinase PI3K/Akt which is also an important mediator of Cx-43 expression.On the basis of these characteristics of CXCL12 and Akt, the potential of overexpressed CXCL12 to improve Cx43 expression via PI3K/Akt pathway was investigated.Mesenchymal stem cells were transfected with adenovirus for increasing CXCL12 secretion.Connexin40, Connexin43, Connexin45 and Akt enzyme were evaluted by Western blot analysis.Transfection CXCL12 resulted increased CXCL12 in situ.Increased CXCL12 induced elevated Connexin40, Connexin43 and Connexin45 expression,which was established by activated PI3K/Akt pathway.Increased CXCL12 leads to enhanced expression of Connexin40, Connexin43 and Connexin45 through PI3K/Akt pathway,which may augment mesenchymal stem cell survival and integration in the infracted heart.



Key wordsMesenchymal stem cells      CXCL12 chemokine      Connexin43      Cell transplantation     
Received: 27 June 2011      Published: 25 April 2012
ZTFLH:  Q786 R541.4  
Cite this article:

CHI Xiao-wei, HOU Jing-bo, MENG Jia, ZHANG Yi-na. CXCL12 Chemokine Up-regulates Connexins Expression in Mesenchymal Stem Cells Through PI3K/Akt Pathway. China Biotechnology, 2012, 32(04): 18-21.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2012/V32/I04/18


[1] Johnstone S R,Best A K,Wright C S,et al. Enhanced connexin 43 expression delays intra-mitoitc duration and cell cycle traverse independently of gap junction channel function.J Cell Biochem,2010,110(3): 772-782.

[2] Rottlaneder D,Bonegler K,Wolny M,et al. Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes. J Clin Invest, 2010,120(5):1441-1453.

[3] Celeste M N,Christopher S.Cell-cell signaling by direct contact increases cell proliferation via a PI3K-dependent signal.FEBS Let,2002,514:238-242.

[4] Song H,Hwang H J,Chang W,et al. Cardiomyocytes from phorbol myristate acetateactivated mesenchymal stem cells restore electromechanical function in infarcted rat hearts.PNAS,2011,108(1):296-301.

[5] Mcspadden L C,Kirkton R D,Bursac N.Electronic loading of anisotropic cardiac monolayers by unexcitable cells depends on connexin type and expression level.Am J Physiol Cell Physiol,2009,297:339-351.

[6] Dawn M P,Rebecca Y K,Nima B,et al.Structrual coupling of cardiomyocytes and noncardiomyocytes:quantitative comparisons using a novel micropatterned cell pair assay. Am J Physiol Heart Circ Physiol,2008,295:390-400.

[7] Zhang M,Mal N,Kiedrowski M,et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J,2007,21: 3197-3207.

[8] Pasha Z,Wang Y G,Sheikh R,et al.Precinditioning enhances cell survival and differentiation of stem cells during transplantation in infracted myocardium.Cardiovas Res,2008,77:134-142.

[9] Saxena A,Fish J E,White M D,et al.Stromal cell-derived factor-1 is cardioprotective after myocardial infarction.Circulation,2008,117: 2224-2231.

[10] Xia X, Batra N, Shi Q,et al. Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/beta-catenin signaling. Mol Cell Biol,2010, 30(1):206-219.

[11] Lu G, Haider H K, Jiang S,et al.Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin43.Circulation,2009,119(19): 2587-2596.

[12] Bhattacharjee R, Kaneda M, Nakahama K,et al. The steady-state expression of connexin43 is maintained by the PI3K/Akt in osteoblasts. Biochem Biophys Res Commun,2009,382(2):440-444.

[1] WANG Yu-xuan,CHEN Ting,ZHANG Yong-liang. Research Progress on the Biological Function of MiR-148[J]. China Biotechnology, 2021, 41(7): 74-80.
[2] LI Kai-xiu,SI Wei. Progress in the Treatment of Inflammatory Bowel Diseases by Exosomes Derived from Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(7): 66-73.
[3] ZHAO Jiu-mei,WANG Zhe,LI Xue-ying. Role of Signal Pathways and Related Factors Regulating Cartilage Formation in Bone Differentiation of Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(10): 62-72.
[4] CHEN Fei,WANG Xiao-bing,XU Zeng-hui,QIAN Qi-jun. Molecular Mechanism and Clinical Research Progress of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus[J]. China Biotechnology, 2020, 40(7): 59-69.
[5] YUAN Ya-kun,LIU Guang-yang,LIU Yong-jun,XIE Ya-fang,WU Hao. Comparison of Research and Clinical Transformation on Mesenchymal Stem Cells between China and the US[J]. China Biotechnology, 2020, 40(4): 97-107.
[6] CHEN Li-jun,QU Jing-jing,XIANG Charlie. Therapeutic Potentials, Clinical Studies, and Application Prospects of Mesenchymal Stem Cells in 2019 Novel Coronavirus (COVID-19)[J]. China Biotechnology, 2020, 40(11): 43-55.
[7] ZHU Yongzhao,TAO Jin,REN Meng-meng,XIONG Ran,HE Ya-qin,ZHOU Yu,LU Zhen-hui,DU Yong,YANG Zhi-hong. Autophagy Protects Against Apoptosis of Human Placental Mesenchymal Stem Cells of Fetal Origin Induced by Tumor Necrosis Fator-α[J]. China Biotechnology, 2019, 39(9): 62-67.
[8] Wen-wen SHI,Lei ZHANG. Current Research of Micro Mechanical Environmental Effects on Mesenchymal Stem Cells’ Differentiation[J]. China Biotechnology, 2018, 38(8): 76-83.
[9] Yan ZHENG,Huan YAO,Ke YANG. SFRP5 Inhibites Osteogenic Differentiation of Human Umbilical Cord-derived Mesenchymal Stem Cells Induced by BMP9[J]. China Biotechnology, 2018, 38(7): 7-13.
[10] YUAN Ya-hong, ZHAO Shan-shan, WANG Xiao-li, TENG Zhi-ping, LI Dong-sheng, ZENG Yi. HIV-1 Tat Protein Inhibits the Hematopoiesis Support Function of Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2017, 37(6): 1-8.
[11] CAO Jun-jie, LI Ai-fang, WEI Ya-lin, LIAN Jing, TANG Min. Role of Notch Signaling Pathway in Bone Morphogenetic Protein 4-induced Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells and Its Mechanism[J]. China Biotechnology, 2017, 37(4): 48-55.
[12] CHEN Gang, WU Jun, ZHU He, YU Tian-fei. Progress of Stem Cell Therapy in Spinal Cord Injury[J]. China Biotechnology, 2017, 37(2): 88-92.
[13] ZHAO Zheng-de, CHEN Zhen-yin, ZHANG Hui-nan, GONG Jian-ping, XU Shao-dan, LUO Zhong-li. Effects of Self-assembling Peptide Hydrogel Scaffolds for Three-dimensional Culture on Biological Behavior and Capability of Myocardium Differentiation in Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2017, 37(11): 45-51.
[14] MAO Kai-yun, FAN Yue-lei, WANG Yue, LU Jiao, CHEN Da-ming. Development Status and Trend Analysis of Mesenchymal Stem Cells Therapeutic Products[J]. China Biotechnology, 2017, 37(10): 126-135.
[15] ZHANG Qing-fang, LIU Ru-ming, XIAO Jian-hui. Application of Hyaluronic Acid on the Cartilage Differentiation of Mesenchymal Stem Cells[J]. China Biotechnology, 2016, 36(6): 92-99.